Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: A case report

Journal of Ophthalmic Inflammation and Infection

Volumn 3, Issue 1, 2013, Pages 1-5

  Bourgault, Serge ^a,b   Aroichane, Maryam ^a   Wittenberg, Leah A ^a   Lavallée, Andréane ^a,b   Ma, Patrick E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cystoid macular edema; Dexamethasone intravitreal implant; Ozurdex ; Panuveitis; Pediatric uveitis; Uveitic macular edema; Uveitis

Indexed keywords

CALCIUM; DEXAMETHASONE; FOLIC ACID; HOMATROPINE; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RIFAMPICIN; TRIAMCINOLONE ACETONIDE;

ABSENCE; ANTERIOR EYE CHAMBER; ARTICLE; BILATERAL GRANULOMATOUS IDIOPATHIC PANUVEITIS; CALCIUM BLOOD LEVEL; CASE REPORT; CHILD; EYE INFLAMMATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN SC DISEASE; HUMAN; INTRAOCULAR PRESSURE; INTRAVITREAL IMPLANT; LACRIMAL GLAND; LATENT TUBERCULOSIS; LOCAL THERAPY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; SCHOOL CHILD; SLIT LAMP; SUBCAPSULAR CATARACT; SUBRETINAL FLUID; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULIN TEST; UVEITIS; VISION; VISUAL ACUITY; VITRECTOMY; VITREOUS BIOPSY;

EID: 84891455982     PISSN: None     EISSN: 18695760     Source Type: Journal    
DOI: 10.1186/1869-5760-3-61     Document Type: Article

References (14)

1. Perkins ES (1966) Pattern of uveitis in children. Br J Ophthalmol 50:169-185
2. Cunningham ET, Jr (2000) Uveitis in children. Ocul Immunol Inflamm 8:251-261
3. Rosenberg KD, Feuer WJ, Davis JL (2004) Ocular complications of pediatric uveitis. Ophthalmology 111:2299-2306
4. Nagpal A, Leigh JF, Acharya NR (2008) Epidemiology of uveitis in children. Int Ophthalmol Clin 48:1-7
5. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492-513
6. Smith JA, Mackensen F, Sen N, Leigh JF, Watkins AS, Pyatetsky D, Tessler HH, Nussenblatt RB, Rosenbaum JT, Reed GF, Vitale S, Smith JR, Goldstein DA (2009) Epidemiology and course of disease in childhood uveitis. Ophthalmology 116:1544-1551
7. McDonough AK, Curtis JR, Saag KG (2008) The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20:131-137
8. Kok H, Lau C, Maycock N, McCluskey P, Lightman S (2005) Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112:1916-1921
9. van Kooij B, Rothova A, de Vries P (2006) The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm 14:73-85
10. Lowder C, Belfort R, Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545-553
11. Taylor SR, Tomkins-Netzer O, Joshi L, Morarji J, McLoone E, Lightman S (2012) Dexamethasone implant in pediatric uveitis. Ophthalmology 119:2412
12. Chin HS, Park TS, Moon YS, Oh JH (2005) Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 25:556-560
13. Chang-Lin JE, Burke JA, Peng Q, Lin T, Orilla WC, Ghosn CR, Zhang KM, Kuppermann BD, Robinson MR, Whitcup SM, Welty DF (2011) Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci 52:4605-4609
14. Chang-Lin JE, Attar M, Acheampong A, Robinson MR, Whitcup SM, Kuppermann BD, Welty D (2011) Pharmacokinetics and pharmacodynamics of the sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52:80-86